Yishay Carmiel and Roy Zanbel of Apollo Defend explore the state of voice AI, detailing the shift from cascaded models to end-to-end speech-to-speech systems. They break down the imminent security threats, including accessible voice cloning and sophisticated agent-based attacks, and discuss the nascent defense mechanisms and the urgent need for a new layer of voice security for governments, enterprises, and consumers.
Chai Discovery's co-founders discuss Chai 2, their new generative AI platform for antibody design. It achieves a nearly 20% hit rate from just 20 computational attempts, a 100-fold improvement over previous methods, signaling a shift from drug discovery to drug engineering.
Experts from Isomorphic Labs discuss how AI, particularly models like AlphaFold3, is revolutionizing drug discovery. They explain the shift from the slow, iterative process of traditional methods to a new era where generative AI can design novel molecules, optimize for multiple biological properties simultaneously, and pave the way for personalized medicine.